ETNB
89bio Inc

1,689
Loading...
Loading...
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
93

Frequently Asked Questions

What is Market Cap of 89bio Inc?
What is the 52-week high for 89bio Inc?
What is the 52-week low for 89bio Inc?
What is 89bio Inc stock price today?
What was 89bio Inc stock price yesterday?
What is the PE ratio of 89bio Inc?
What is the Price-to-Book ratio of 89bio Inc?
What is the 50-day moving average of 89bio Inc?
How many employess does 89bio Inc has?

Latest ETNB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.